Results 1 to 10 of about 4,318 (114)

Eosinophilic gastritis without peripheral eosinophilia and atopy: A case report [PDF]

open access: yesClinical Case Reports (discontinued), 2022
Eosinophilic gastritis (EG) is characterized by eosinophilic infiltration of any gastric layers. We report a 65‐year‐female presenting with abdominal pain and vomiting for two months.
Shekhar Poudel   +2 more
exaly   +3 more sources

Case Report: Eosinophilic gastritis with pyloric stenosis in immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome [PDF]

open access: yesFrontiers in Pediatrics, 2022
Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome is a rare X-linked recessive immunodeficiency caused by mutations in the forkhead box protein 3 (FOXP3) gene. IPEX is characterized by the onset of intractable diarrhea, type
Yizhong Wang   +2 more
exaly   +4 more sources

Asymptomatic Eosinophilic Infiltration with Endoscopic and Histological Findings Consistent with Eosinophilic Gastritis [PDF]

open access: yesCase Reports in Gastroenterology, 2021
Eosinophilic gastritis often presents with gastrointestinal symptoms in the absence of abnormal endoscopic findings. On the other hand, endoscopic changes due to eosinophilic infiltration in an asymptomatic patient are rare.
Kazuki Yamamoto   +2 more
doaj   +2 more sources

Chronic Eosinophilic Gastritis Presenting as Gastric Outlet Obstruction in a Young Man: A Case Report [PDF]

open access: yesThe Korean Journal of Helicobacter and Upper Gastrointestinal Research
Eosinophilic gastritis, a relatively rare condition characterized by eosinophilic infiltration of the gastrointestinal wall, has a chronic course involving relapses and remissions.
Na Young Kim   +5 more
doaj   +2 more sources

Severe anaemia after gastric biopsy in an infant with eosinophilic gastritis [PDF]

open access: yesItalian Journal of Pediatrics, 2019
Background Eosinophilic gastrointestinal disorders (EGID) are characterized by eosinophilic inflammation and are subclassified according to the affected site(s) as eosinophilic esophagitis, eosinophilic gastritis, eosinophilic enteritis and eosinophilic ...
Alessandro Daidone   +3 more
doaj   +2 more sources

Development and content validation of a symptom assessment for eosinophilic gastritis and eosinophilic gastroenteritis in adults and adolescents [PDF]

open access: yesOrphanet Journal of Rare Diseases, 2021
Background A patient reported outcome (PRO) instrument with evidence of validity and reliability for assessing symptoms of eosinophilic gastritis (EG) and eosinophilic gastroenteritis (EGE) is needed to measure treatment benefit in clinical trials.
Calvin N. Ho   +6 more
doaj   +2 more sources

Eosinophilic Gastritis Presenting as Tissue Necrosis [PDF]

open access: yesClinical Endoscopy, 2015
Eosinophilic gastroenteritis is very rare disorder that is characterized by eosinophilic infiltration of the gastrointestinal tract in the absence of any definite causes of eosinophilia.
Yong Min Jo   +5 more
doaj   +2 more sources

Dupilumab as a rescue therapy for steroid-dependent eosinophilic gastritis in a child unresponsive to elimination diet: a case report [PDF]

open access: yesFrontiers in Pediatrics
BackgroundEosinophilic gastrointestinal diseases (EGIDs) are chronic, rare and heterogeneous disorders characterized by eosinophilic infiltration of gastrointestinal tract, resulting in gastrointestinal dysfunction.
Marisa Piccirillo   +10 more
doaj   +2 more sources

Initial Validation of the Eosinophilic Gastritis and Gastroenteritis Quality of Life Scale [PDF]

open access: yesGastro Hep Advances
Background and Aims: Eosinophilic gastrointestinal disorders (EGIDs) are chronic immune-mediated conditions characterized by gastrointestinal symptoms and gut eosinophilia.
Tiffany H. Taft   +2 more
doaj   +2 more sources

Eosinophilic Gastritis in a Patient Previously Treated with Dupilumab [PDF]

open access: yesCase Reports in Gastrointestinal Medicine, 2020
A 77-year-old Japanese man with bronchial asthma was treated with dupilumab. Dupilumab treatment was discontinued at the patient’s request after two injections separated by a 2-week interval.
Masaya Iwamuro   +6 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy